Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alcamena Stem Cell Therapeutics

Clinical trials sponsored by Alcamena Stem Cell Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New nerve pain drug ASCT-83 enters first human safety trial Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New nerve pain drug ASCT-83 enters first human safety trial

Symptom relief Recruiting now

This early-stage study tests whether a new drug called ASCT-83 is safe for people with nerve pain. It involves 72 healthy adults who will receive either the drug or a placebo. The study will also measure how the drug moves through the body. Results will help decide safe doses for…

Phase 1 • Sponsor: Alcamena Stem Cell Therapeutics • Aim: Symptom relief

Last updated Jun 27, 2026 14:00 UTC